Product NDC: | 64125-136 |
Proprietary Name: | Benztropine Mesylate |
Non Proprietary Name: | benztropine mesylate |
Active Ingredient(s): | .5 mg/1 & nbsp; benztropine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64125-136 |
Labeler Name: | Excellium Pharmaceutical, Inc, |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090168 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121201 |
Package NDC: | 64125-136-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (64125-136-01) |
NDC Code | 64125-136-01 |
Proprietary Name | Benztropine Mesylate |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (64125-136-01) |
Product NDC | 64125-136 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | benztropine mesylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121201 |
Marketing Category Name | ANDA |
Labeler Name | Excellium Pharmaceutical, Inc, |
Substance Name | BENZTROPINE MESYLATE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |